Publication | Open Access

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Surgical OncologyEsophageal CancerGastrointestinal OncologyGastro-oesophageal Junction AdenocarcinomaMedicineGastroenterologySurgeryUpper Gastrointestinal SurgeryAdvanced GastricCancer TreatmentOncologyRadiation OncologyEsophageal SurgeryRamucirumab Monotherapy